These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39204320)
1. Long-Circulating and Brain-Targeted Liposomes Loaded with Isoliquiritigenin: Formation, Characterization, Pharmacokinetics, and Distribution. Song W; Bai L; Xu P; Zhao Y; Zhou X; Xiong J; Li X; Xue M Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204320 [TBL] [Abstract][Full Text] [Related]
2. Long-Circulation and Brain Targeted Isoliquiritigenin Micelle Nanoparticles: Formation, Characterization, Tissue Distribution, Pharmacokinetics and Effects for Ischemic Stroke. Song W; Bai L; Yang Y; Wang Y; Xu P; Zhao Y; Zhou X; Li X; Xue M Int J Nanomedicine; 2022; 17():3655-3670. PubMed ID: 35999993 [TBL] [Abstract][Full Text] [Related]
3. Preparation, Properties and Preclinical Pharmacokinetics of Low Molecular Weight Heparin-modified Isoliquiritigenin-loaded Solid Lipid Nanoparticle. Zhang X; Qiao H; Chen Y; Li L; Xia H; Shi Y Iran J Pharm Res; 2016; 15(3):269-282. PubMed ID: 27980562 [TBL] [Abstract][Full Text] [Related]
4. Preparation, in vitro and in vivo evaluation of isoliquiritigenin-loaded TPGS modified proliposomes. Liu J; Wang Q; Adu-Frimpong M; Wei Q; Xie Y; Zhang K; Wei C; Weng W; Ji H; Toreniyazov E; Xu X; Yu J Int J Pharm; 2019 May; 563():53-62. PubMed ID: 30890449 [TBL] [Abstract][Full Text] [Related]
5. Preparation, Characterization, Pharmacokinetics and Biodistribution of Baicalin-Loaded Liposome on Cerebral Ischemia-Reperfusion after i.v. Administration in Rats. Li N; Feng L; Tan Y; Xiang Y; Zhang R; Yang M Molecules; 2018 Jul; 23(7):. PubMed ID: 30018228 [TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of isoliquiritigenin-loaded F127/P123 polymeric micelles. Xie YJ; Wang QL; Adu-Frimpong M; Liu J; Zhang KY; Xu XM; Yu JN Drug Dev Ind Pharm; 2019 Aug; 45(8):1224-1232. PubMed ID: 30681382 [TBL] [Abstract][Full Text] [Related]
7. Development of long-circulating lapachol nanoparticles: formation, characterization, pharmacokinetics, distribution and cytotoxicity. Chen Q; Bai L; Zhou X; Xu P; Li X; Xu H; Zheng Y; Zhao Y; Lu S; Xue M RSC Adv; 2020 Aug; 10(50):30025-30034. PubMed ID: 35518271 [TBL] [Abstract][Full Text] [Related]
8. Preparation and Zhang R; Yang J; Luo Q; Shi J; Xu H; Zhang J Drug Deliv; 2022 Dec; 29(1):2217-2233. PubMed ID: 35815765 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of Oral Bioavailability and Anti-hyperuricemic Activity of Isoliquiritigenin via Self-Microemulsifying Drug Delivery System. Zhang K; Wang Q; Yang Q; Wei Q; Man N; Adu-Frimpong M; Toreniyazov E; Ji H; Yu J; Xu X AAPS PharmSciTech; 2019 Jun; 20(5):218. PubMed ID: 31187334 [TBL] [Abstract][Full Text] [Related]
10. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability. Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942 [TBL] [Abstract][Full Text] [Related]
11. Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes. Wei Y; Guo J; Zheng X; Wu J; Zhou Y; Yu Y; Ye Y; Zhang L; Zhao L Int J Nanomedicine; 2014; 9():3623-30. PubMed ID: 25120360 [TBL] [Abstract][Full Text] [Related]
12. Colon-specific delivery of isoliquiritigenin by oral edible zein/caseate nanocomplex for ulcerative colitis treatment. Xiao M; Wu S; Cheng Y; Ma J; Luo X; Chang L; Zhang C; Chen J; Zou L; You Y; Zhang J Front Chem; 2022; 10():981055. PubMed ID: 36157029 [TBL] [Abstract][Full Text] [Related]
13. Isoliquiritigenin Containing PH Sensitive Micelles for Enhanced Anti-Colitis Activity. Shi F; Du M; Wang Q; Adu-Frimpong M; Li C; Zhang X; Ji H; Toreniyazov E; Cao X; Wang Q; Xu X J Pharm Sci; 2024 Apr; 113(4):918-929. PubMed ID: 37777013 [TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect. Liu H; Zhang R; Zhang D; Zhang C; Zhang Z; Fu X; Luo Y; Chen S; Wu A; Zeng W; Qu K; Zhang H; Wang S; Shi H Int J Nanomedicine; 2022; 17():227-244. PubMed ID: 35068931 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide. Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053 [TBL] [Abstract][Full Text] [Related]
16. Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII. Lu L; Ding Y; Zhang Y; Ho RJ; Zhao Y; Zhang T; Guo C Int J Nanomedicine; 2018; 13():1927-1944. PubMed ID: 29636610 [TBL] [Abstract][Full Text] [Related]
17. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer. Wang G; Yu Y; Wang YZ; Yin PH; Xu K; Zhang H Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1231-1249. PubMed ID: 32985258 [TBL] [Abstract][Full Text] [Related]
18. Geniposide-Loaded Liposomes for Brain Targeting: Development, Evaluation, and In Vivo Studies. Wan J; Long Y; Liu S; Zhang Y; Xiang Y; Li D; Shi A; Shuang Y; Li Y; He Y; Li N; Guan Y AAPS PharmSciTech; 2021 Aug; 22(7):222. PubMed ID: 34409515 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction. Guo BH; Cheng Y; Lin LP; Lin DH; Wu W J Liposome Res; 2011 Sep; 21(3):255-60. PubMed ID: 21545336 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo studies of galactose-modified liver-targeting liposomes. Guo B; Cheng Y; Li N; Li X; Jin M; Li T; Li J J Drug Target; 2013 Apr; 21(3):257-264. PubMed ID: 23163746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]